The Effect of Position on Pain, Bleeding, Hematoma and Vital Signs After Transfemoral Coronary Angiography
Launched by MERSIN UNIVERSITY · Jan 25, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how the position a patient is placed in after a specific heart procedure called transfemoral coronary angiography affects their pain, bleeding, bruising, and vital signs (like heart rate and blood pressure). The researchers want to find out if changing the patient's position can help improve their comfort and safety during recovery.
To be eligible for this study, participants must be at least 18 years old, able to understand and communicate in Turkish, and scheduled to have the angiography procedure. They should be in good health, without any serious bleeding issues or chronic pain, and not taking certain medications that might complicate the study. If you join the trial, you can expect to be monitored closely after the procedure to see how the different positions impact your recovery. It's important to know that the trial is not currently recruiting participants but will be starting soon.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Written and verbal permission was obtained to participate in the research.
- • Able to read, write, speak and understand Turkish
- • Those who are over 18 years old
- • Planned transfemoral angiography was performed
- • Having normal prothrombin time (PT) and international normalization ratio (INR)
- • Being conscious, fully oriented and cooperative, and open to communication.
- • Those whose general condition is good and comfortable (vital signs are within normal limits)
- • Not using any sedative medication,
- • Those who have not previously had widespread hemorrhage, large hematoma, or a pain sensation greater than 4.5 on the visual pain scale
- • Patients with imaging, medical treatment, stents, balloons, stents and balloons as a result of the procedure
- • Not having any psychiatric disease
- Exclusion Criteria:
- • Exclusion criteria;
- • People with hemophilia or other coagulation defects
- • Those with active hemorrhage
- • Previously treated with streptokinase
- • Using more than 2 anticoagulants or antiplatelets
- • Those who have had back surgery/herniated disc,
- • Having chronic waist, back or leg pain
- • Using any of the complementary and integrated methods
- • Do not use any analgesic before, during and after transfemoral angiography.
- • Radial angiography procedure was performed
- • Patients coming to the service with sandbags
- • Those who had any health problems or lost their lives during the application process
- • Those who cannot continue the research for any reason
- • Patients who wish to leave the study with their own consent
About Mersin University
Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adana, , Turkey
Adana, Yüreğir, Turkey
Patients applied
Trial Officials
Digdem LAFCI BAKAR, PhD
Principal Investigator
Mersin University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported